Novartis AG ADS (NY:NVS)
Delayed: 74.36 +0.54 (0.73%)
Trade Now!
Previous Close $73.82    52 Week High $75.73 
Open $74.36    52 Week Low $51.20 
Day High $74.43    P/E N/A 
Day Low $73.85    EPS $0.00 
Volume 1,008,886       

Friends, Peers and Foes (?): NOVN, PFE, ABT, BIIB, SNY (more...)

May 24, 2013 11:51 AM Form 6-K NOVARTIS AG For: May 24
May 20, 2013 11:01 AM UPDATE: Lazard Capital Downgrades Warner Chilcott (WCRX), Says Deal Could Fall Through
May 16, 2013 08:16 AM Novartis (NVS) has no intention of pursing a bid for Actavis, Inc. (ACT)
May 10, 2013 01:20 AM Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
Apr 29, 2013 10:10 AM Biogen Idec (BIIB) Pops on Strong Tecfidera Rx Growth
Apr 26, 2013 06:52 PM Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
Apr 25, 2013 01:20 AM Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign
Apr 24, 2013 10:41 AM Form 6-K NOVARTIS AG For: Mar 31
Apr 24, 2013 06:52 AM Form 6-K NOVARTIS AG For: Apr 24
Apr 23, 2013 06:03 PM Trading Radar for 04/24: Ford (F), Boeing (BA), Zynga (ZNGA), Sprint (S), SUPERVALU (SVU) Report
View All Articles

Entities mentioned with NVS

View All Entities